ChemicalBook Product Catalog Pharmaceutical intermediates Bulk Drug Intermediates (S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one

(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one

(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one Basic information
Product Name:(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one
Synonyms:(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one;2-Oxazolidinone,3-[(2S,4R)-4-bromo-2-(1-methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylmethyl)-, (4S)-;(4S)-4-benzyl-3-[(2S,4R)-4-bromo-2-isopropyl-4-[(2S,4S)-4-isopropyl-5-oxo-tetrahydrofuran-2-yl]butanoyl]oxazolidin-2-one;3(S)-Isopropyl-5(S)-{1 (R)-bromo-4-methyl-3(S)-[(4(S)-benzyloxazolidin-2-on-3-yl)-carbonyl]-pentyl}-tetrahydrofuran-2-one
CAS:173154-00-2
MF:C24H32BrNO5
MW:494.42
EINECS:605-664-0
Product Categories:aliskiren
Mol File:173154-00-2.mol
(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one Structure
(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one Chemical Properties
Melting point 91.2 °C
Boiling point 626.2±30.0 °C(Predicted)
density 1.315±0.06 g/cm3(Predicted)
pka-2.37±0.40(Predicted)
Safety Information
MSDS Information
(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one Usage And Synthesis
(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one Preparation Products And Raw materials
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.